Clinical Trial Update: Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

View source ↗

Summary

A clinical trial evaluating prognostic factors for hepatocellular carcinoma and liver transplantation in patients with MASLD/MASH; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Metabolic Dysfunction-associated Steatohepatitis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatocellular Carcinoma | Status: RECRUITING